Search

Drug Profiles Catalysts Company Profiles Impact Events Target
Indication Trials KOL Insight Special Reports All

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
04/23/14 Johnson & Johnson (JNJ) Sylvant for Castleman's Disease Subscribers Only Subscribers Only     Subscribers Only
04/23/14 Spectrum (SPPI) Melphalan IV for Multiple Myeloma (MM) Subscribers Only Subscribers Only     Subscribers Only
04/22/14 Novartis (NVS) Votrient (Oral) for Renal Cell Cancer (RCC) Subscribers Only Subscribers Only     Subscribers Only
04/22/14 Pfizer (PFE) Xeljanz for Psoriasis Subscribers Only Subscribers Only     Subscribers Only
04/22/14 Salix (SLXP) Relistor SC for Opioid Induced Constipation Subscribers Only Subscribers Only     Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
04/23/14 Subscribers Only Subscribers Only Company - Earnings Announcement
04/23/14 Subscribers Only Subscribers Only Trial Data - Published Results
04/24/14 Subscribers Only Subscribers Only Trial Data - Top-Line Results
04/24/14 Subscribers Only Subscribers Only Trial Data - Top-Line Results
04/24/14 Subscribers Only Subscribers Only Trial Data - Top-Line Results